Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis have?
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis published?
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis has 2012 year in the ScholarIQ index.
What is the open-access status of Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis?
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis has closed oa status in the ScholarIQ index.
What is the DOI of Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis?
The DOI for Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis is on the source record.
What is the PMID of Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis?
The PMID for Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis?
The OpenAlex for Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis is on the source record.